Oireachtas Joint and Select Committees
Wednesday, 21 November 2018
Joint Oireachtas Committee on Health
Evaluating Orphan Drugs: Discussion (Resumed)
9:00 am
Mr. Philip Watt:
I would defend that somewhat. Even in terms of our experience around Orkambi, it got a significant reduction in terms of what was offered originally. I cannot reveal the price. It brought in an innovative system whereby if better drugs come along in the future, we will automatically get them. That is being copied by other countries so there are occasions when it can get it right. We need to build on that good practice.